Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-16 Sale | 2022-05-17 9:32 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 17,448 | $3.95 | $68,920 | 312,905 (Direct) | View |
| 2022-05-04 Purchase(A) | 2022-05-09 4:28 pm | Rezolute Inc. | RZLT | Labrucherie Gil M Director | 52,631 | $3.8 | $199,998 | 53,572 (Indirect) | View |
| 2022-05-04 Purchase | 2022-05-06 5:15 pm | Rezolute Inc. | RZLT | Labrucherie Gil M Director | 52,631 | $3.8 | $199,998 | 99,673 (Indirect Direct) | View |
| 2022-02-16 Sale | 2022-02-18 6:14 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 7,579 | $10.95 | $82,990 | 301,603 (Direct) | View |
| 2021-11-16 Sale | 2021-11-18 6:06 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 24,149 | $13.1 | $316,391 | 256,682 (Direct) | View |
| 2021-08-16 Sale | 2021-08-18 6:58 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 10,867 | $13.76 | $149,481 | 240,231 (Direct) | View |
| 2021-05-17 Sale | 2021-05-19 7:04 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 7,898 | $18.3 | $144,533 | 251,098 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 7:03 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 7,977 | $22.37 | $178,445 | 258,996 (Direct) | View |
| 2021-02-02 Sale | 2021-02-04 8:42 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 150,000 | $19.86 | $2,979,629 | 341,973 (Direct) | View |
| 2020-11-16 Sale | 2020-11-18 7:03 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 8,276 | $16.93 | $140,113 | 226,973 (Direct) | View |
| 2020-09-17 Sale | 2020-09-21 8:59 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 2,000 | $19.96 | $39,920 | 235,249 (Direct) | View |
| 2020-08-17 Sale | 2020-08-19 6:37 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 8,245 | $19.67 | $162,199 | 237,249 (Direct) | View |
| 2020-05-18 Sale | 2020-05-20 6:29 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 7,727 | $22.54 | $174,155 | 245,494 (Direct) | View |
| 2020-02-18 Sale | 2020-02-20 6:37 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 5,938 | $22.35 | $132,714 | 253,221 (Direct) | View |
| 2019-11-18 Sale | 2019-11-20 7:04 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 8,863 | $17.97 | $159,268 | 219,009 (Direct) | View |
| 2019-11-13 Sale | 2019-11-15 6:09 pm | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 25,000 | $19.79 | $494,750 | 227,872 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-31 Option Award | 2024-09-04 8:36 pm | N/A 2034-08-30 | ACELYRIN Inc. | SLRN | Labrucherie Gil M CFO and CBO | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 6:59 pm | N/A 2034-05-22 | ACELYRIN Inc. | SLRN | Labrucherie Gil M CFO and CBO | 184,042 | $0 | 184,042 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 12:08 pm | N/A 2034-01-23 | Rezolute Inc. | RZLT | Labrucherie Gil M Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-11 6:26 pm | N/A 2034-01-08 | ACELYRIN Inc. | SLRN | Labrucherie Gil M Chief Financial Officer | 855,513 | $0 | 855,513 (Direct) | View |
| 2023-10-04 Other | 2023-10-06 5:53 pm | N/A N/A | ACELYRIN Inc. | SLRN | Labrucherie Gil M Chief Financial Officer | 40,763 | $0 | 87,776 (Indirect) | View |
| 2023-08-17 Option Award | 2023-08-21 4:48 pm | N/A 2033-08-16 | ACELYRIN Inc. | SLRN | Labrucherie Gil M Chief Financial Officer | 254,939 | $0 | 261,189 (Direct) | View |
Ownership | 2023-08-03 8:08 pm | N/A N/A | ACELYRIN Inc. | SLRN | Labrucherie Gil M Interim CFO | 0 | $0 | 6,250 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 5:43 pm | N/A 2032-06-23 | Rezolute Inc. | RZLT | Labrucherie Gil M Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-05-15 Option Award | 2022-05-17 9:32 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 28,750 | $0 | 312,905 (Direct) | View |
| 2021-12-16 Option Award | 2021-12-20 8:23 pm | N/A 2029-12-15 | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 146,950 | $0 | 403,182 (Direct) | View |
| 2021-11-15 Option Award | 2021-11-17 6:04 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 40,150 | $0 | 280,831 (Direct) | View |
| 2021-10-12 Option Award | 2021-10-14 9:05 pm | N/A 2027-12-11 | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 71,550 | $0 | 71,550 (Direct) | View |
| 2021-06-14 Option Award | 2021-07-14 9:03 pm | N/A 2031-06-14 | Rezolute Inc. | RZLT | Labrucherie Gil M Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-04 8:42 pm | 2017-02-06 2021-02-05 | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 150,000 | $0 | 341,973 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-04 8:42 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 125,000 | $8.8 | 341,973 (Direct) | View |
| 2020-12-18 Option Award | 2020-12-22 6:48 pm | N/A 2028-12-17 | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 111,500 | $0 | 338,473 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-16 9:34 pm | N/A 2027-12-11 | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 140,700 | $0 | 359,709 (Direct) | View |
Ownership | 2019-11-27 12:09 pm | N/A N/A | Rezolute Inc. | RZLT | Labrucherie Gil M Director | 0 | $0 | 94,084 (Indirect) | View |
| 2019-11-13 Exercise | 2019-11-15 6:09 pm | 2016-02-08 2020-02-07 | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 25,000 | $0 | 227,872 (Direct) | View |
| 2019-11-13 Exercise | 2019-11-15 6:09 pm | N/A N/A | NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO | 25,000 | $7.21 | 227,872 (Direct) | View |